Determinants of therapeutic resistance in glioblastomas: Lessons learned from RTOG 0211 and beyond. Background: Due to an ability to reverse blood-brain barrier permeability, antiangiogenic agents ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback